`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner,
`
`v.
`
`HORIZON THERAPEUTICS, INC.,
`Patent Owner.
`
`_____________________
`
`Case IPR2017-01767
`Patent 9,254,278
`_____________________
`
`PETITIONER PAR PHARMACEUTICAL, INC.’S
`UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`IPR2017-01767
`Patent No. 9,254,278
`Par’s Updated Exhibit List
`
`
`List of Exhibits and Abbreviations for Exhibits
`
`EXHIBIT
`NO.
`
`1001
`
`DESCRIPTION
`
`U.S. Patent No. 9,254,278 to Scharschmidt et
`al., filed August 3, 2015, issued February 9,
`2016
`
`ABBREVIATION
`(if applicable)
`
`the ’278 Patent
`
`1002
`
`1003
`
`1004
`
`Declaration of Dr. Neal Sondheimer
`
`Curriculum vitae of Dr. Neal Sondheimer
`
`U.S. Patent Publication No. 2010/0008859,
`filed January 7, 2009, published January 14,
`2010
`
`1005 Moser et al., Argininoscuccinic Aciduria
`Report of Two New Cases and Demonstration
`of Intermittent Elevation of Blood Ammonia,
`42 Am. J. Medicine, 9-26 (1967)
`
`1006
`
`1007
`
`Blau, Duran, Blaskovics, Gibson (editors),
`Physician’s Guide to the Laboratory
`Diagnosis of Metabolic Diseases, 261–276 (2d
`ed. 1996)
`
`Simell et al., Waste Nitrogen Excretion Via
`Amino Acid Acylation: Benzoate and
`Phenylacetate in Lysinuric Protein
`Intolerance, 20 Pediatric Research, 1117–1121
`(1986)
`
`1008
`
`Feillet et al., Alternative Pathway Therapy for
`Urea Cycle Disorders, 21 Journal of Inherited
`Metabolic Disease Suppl 1, 101-111 (1998)
`
`
`
`
`
`the ’859
`Publication
`
`Moser
`
`Blau
`
`Simell
`
`Feillet
`
`-1-
`
`
`
`EXHIBIT
`NO.
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`1016
`
`1017
`
`IPR2017-01767
`Patent No. 9,254,278
`Par’s Updated Exhibit List
`
`
`DESCRIPTION
`
`Scientific Discussion for Ammonaps, EMEA,
`1-12 (2005)
`
`Lee et al., Phase 2 comparison of a novel
`ammonia scavenging agent with sodium
`phenylbutyrate in patients with urea cycle
`disorders: Safety, pharmacokinetics and
`ammonia control, 100 Molecular Genetics and
`Metabolism, 221-228 (2010)
`
`Buphenyl Label
`
`ABBREVIATION
`(if applicable)
`
`Ammonaps
`
`Lee
`
`
`
`Prosecution History of U.S. Patent
`No. 8,404,215
`
`the ’215 Parent
`Patent
`
`
`
`
`
`Fernandes
`
`Leonard 2008
`
`Lichter-Konecki
`
`Assignment History of U.S. Patent 8,642,012
`
`’278 Patent Infringement Complaint with
`Return of Service
`
`Fernandes et al., Inborn Metabolic Diseases
`Diagnosis and Treatment, 214-22 (J.
`Fernandes et al., eds., 3d ed. 2002)
`
`Leonard et al., Hypothesis: Proposals for the
`Management of a Neonate at Risk of
`Hyperammonaemia Due to a Urea Cycle
`Disorder, 167 Eur. J. Pediatr. 305-309 (2008)
`
`Lichter-Konecki et al., Ammonia Control in
`Children with Urea Cycle Disorders (UCDs):
`Phase 2 Comparison of Sodium
`Phenylbutyrate and Glycerol Phenylbutyrate,
`103 Molecular Genetics and Metabolism, 323-
`329 (2011)
`
`-2-
`
`
`
`EXHIBIT
`NO.
`
`1018
`
`IPR2017-01767
`Patent No. 9,254,278
`Par’s Updated Exhibit List
`
`
`ABBREVIATION
`(if applicable)
`
`DESCRIPTION
`
`Pandya et al., N-Acetylglutamate Synthetase
`Deficiency: Clinical and Laboratory
`Observations, 14 J. Inher. Metab. Dis. 685-690
`(1991)
`
`Pandya
`
`1019
`
`U.S. Patent No. 5,968,979
`
`1020 McGuire et al., Pharmacology and Safety of
`Glycerol Phenylbutyrate in Healthy Adults and
`Adults with Cirrhosis, 51(6) Hepatology 2077-
`2085 (2010)
`
`the ’979 patent
`
`McGuire
`
`1021
`
`1022
`
`1023
`
`1024
`
`Diaz et al., Phase 3 Blinded, Randomized,
`Crossover Comparison of Sodium
`Phenylbutyrate (NaPBA) and glycerol
`phenylbutyrate (GPB): Ammonia (NH3)
`Control in Adults with Urea Cycle Disorders
`(UCDs), 102 Molecular Genetics and
`Metabolism 276-77 (2011)
`
`Barsotti, Measurement of Ammonia in Blood,
`138 J. Pediatrics, S11-S20 (2001)
`
`Yajima, et al., Diurnal Fluctuations of Blood
`Ammonia Levels in Adult-Type Citrullinemia,
`137 Tokohu J. Ex/ Med, 213-220 (1982)
`
`Batshaw, et al., Treatment of Carbamyl
`Phosphate Synthetase Deficiency with Keto
`Analogues of Essential Amino Acids, 292 New
`Eng. J. Med. 1085−90 (1975)
`
`Diaz
`
`Barsotti
`
`Yajima
`
`Batshaw
`
`-3-
`
`
`
`EXHIBIT
`NO.
`
`1025
`
`DESCRIPTION
`
`Brusilow, Phenylacetylglutamine May Replace
`Urea as a Vehicle for Waste Nitrogen
`Excretion, 29 Pediatric Research, 147-150
`(1991)
`
`1026
`
`Enns Deposition Ex. 1026, Fernandes et al.,
`Inborn Metabolic Diseases Diagnosis and
`Treatment, 214-22 (J. Fernandes et al., eds., 3d
`ed. 2002)
`
`1027
`
`Transcript of July 18, 2018 Deposition of
`Dr. Gregory M. Enns
`
`Reply Declaration of Dr. Neal Sondheimer
`
`1028
`
`
`Dated: August 16, 2018
`
`
`IPR2017-01767
`Patent No. 9,254,278
`Par’s Updated Exhibit List
`
`
`ABBREVIATION
`(if applicable)
`
`Brusilow ’91
`
`
`
`
`
`
`
`
`David H. Silverstein (Reg. No. 61,948)
`AXINN, VELTROP & HARKRIDER LLP
`114 West 47th Street, 22nd Floor
`New York, NY 10036
`(212) 261-5651
`
`Counsel for Petitioner
`Par Pharmaceutical, Inc.
`
`-4-
`
`
`
`IPR2017-01767
`Patent No. 9,254,278
`Certificate of Service
`
`
`CERTIFICATION OF SERVICE
`The undersigned hereby certifies that the above-captioned “PETITIONER
`
`PAR PHARMACEUTICAL, INC.’S UPDATED EXHIBIT LIST” was served in
`
`its entirety on August 16, 2018 upon the following parties via Electronic Mail, as
`
`agreed to by counsel:
`
`
`
`Robert Green: rgreen@greengriffith.com
`Matthew Phillips: mphillips@lpiplaw.com
`Emer Simic: esimic@greengriffith.com
`Dennis Bennett: dennisbennett@globalpatentgroup.com
`Ann Kotze: akotze@greengriffith.com
`
`
`Dated: August 16, 2018
`
`
`
`
`
`David H. Silverstein (Reg. No. 61,948)
`AXINN, VELTROP & HARKRIDER LLP
`114 West 47th Street, 22nd Floor
`New York, NY 10036
`(212) 261-5651
`
`Counsel for Petitioner
`Par Pharmaceutical, Inc.
`
`
`-1-
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
